CRSP - Crispr Therapeutics AG - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRSP is currently covered by 23 analysts with an average price target of $90.3. This is a potential upside of $25.17 (38.65%) from yesterday's end of day stock price of $65.13.

Crispr Therapeutics AG's activity chart (see below) currently has 235 price targets and 231 ratings on display. The stock rating distribution of CRSP is 65.88% BUY, 25.88% HOLD and 8.24% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.8% with an average time for these price targets to be met of 102.07 days.

Highest price target for CRSP is $105, Lowest price target is $32, average price target is $73.35.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 08-Jul-2025. First documented stock forecast 14-Nov-2016.

Currently out of the existing stock ratings of CRSP, 56 are a BUY (65.88%), 22 are a HOLD (25.88%), 7 are a SELL (8.24%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$81

$15.87 (24.37%)

$81

12 days ago
(08-Jul-2025)

8/23 (34.78%)

$26.18 (47.76%)

214

Buy

$105

$39.87 (61.22%)

$105

23 days ago
(27-Jun-2025)

23/28 (82.14%)

$57.51 (121.10%)

255

Buy

$65

$-0.13 (-0.20%)

$65

23 days ago
(27-Jun-2025)

4/4 (100%)

$17.51 (36.87%)

100

Buy

$86

$20.87 (32.04%)

$86

23 days ago
(27-Jun-2025)

12/18 (66.67%)

$38.51 (81.09%)

161

Buy

$82

$16.87 (25.90%)

$82

24 days ago
(26-Jun-2025)

3/15 (20%)

$35.3 (75.59%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?

On average it took 102.07 days on average for the stock forecasts to be realized with a an average price target met ratio 62.8

Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on CRSP

Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?

Maury Raycroft with highest potential upside - $126.61

Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?

Tyler Van Buren with lowest potential downside - -$35.13

Crispr Therapeutics AG in the News

Here's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader Market

CRISPR Therapeutics AG (CRSP) ended the recent trading session at $51.19, demonstrating a -1.88% change from the preceding day’s closing price. This move lagged the S&P 500’s daily loss of 0.79%. Meanwhile, the Dow lost 0.94%, and the Nasdaq, a tech-heavy index, lost 0.92%. The stock of company has risen by 24.63% in the past...

Intellia Gains 29.8% in a Month: How Should You Play the Stock?

Intellia Therapeutics NTLA has put up a stellar performance in the past month. Shares of the company have rallied 29.8% compared with the industry’s rise of 0.4%. The stock has also outperformed the sector and the S&P 500 index in the said timeframe. NTLA Outperforms Industry, Sector and S&P 500Zacks Investment Research Image Source: Zacks...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?